Details

Title Myeloproliferative disorders
Type Stage One
Code HLS033
Requirement Compulsory

Module objective

By the end of the training period trainees will, in respect of myeloproliferative disorders, be able to:

  • analyse, synthesise, evaluate and apply knowledge
  • perform a range of technical and clinical skills and procedures
  • demonstrate the attitudes and behaviours necessary for professional practice as a consultant clinical scientist dealing with the complexities, uncertainties and tensions of professional practice at this level.

Knowledge and understanding

  1. Health and safety legislation and guidance
  2. ACDP categorisation of biological agents
  3. Laboratory safety and containment
  4. Transport regulations

By the end of the training period the trainee will be able to demonstrate the ability to analyse, evaluate and synthesise relevant knowledge and its application to their professional practice in relation to the

  • pathophysiology and classification of myeloproliferative disorders (MPD)
  • diagnostic methods including isotopic evaluation of red cell mass and evolving molecular methods
  • treatment options in the treatment of MPD.

Technical and clinical skills

By the end of the training period the trainee will be able to demonstrate a critical understanding of current relevant research, theory and knowledge and its application to the performance of the following technical procedures and laboratory skills:

  • use laboratory methods to contribute to the diagnosis and monitoring of patients with myeloproliferative disorders
  • understand the therapeutic options available for this group of patients.

Attitudes and behaviours

This module has no attitude and behaviours information.

Specialties

Code Title Action
HLS1-2-1-20 Haematology (Haemostasis and Thrombosis) [v1] View
HLS1-2-2-20 Haematology (Haemato-Oncology) [v1] View
HLS1-2-3-20 Haematology (Transfusion) [v1] View